Loading…

Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings

To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings. Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers...

Full description

Saved in:
Bibliographic Details
Published in:Investigative ophthalmology & visual science 2019-11, Vol.60 (14), p.4691-4700
Main Authors: Nakamura, Natsuko, Tsunoda, Kazushige, Mizuno, Yoshinobu, Usui, Tomoaki, Hatase, Tetsuhisa, Ueno, Shinji, Kuniyoshi, Kazuki, Hayashi, Takaaki, Katagiri, Satoshi, Kondo, Mineo, Kameya, Shuhei, Yoshitake, Kazutoshi, Fujinami, Kaoru, Iwata, Takeshi, Miyake, Yozo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223
cites cdi_FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223
container_end_page 4700
container_issue 14
container_start_page 4691
container_title Investigative ophthalmology & visual science
container_volume 60
creator Nakamura, Natsuko
Tsunoda, Kazushige
Mizuno, Yoshinobu
Usui, Tomoaki
Hatase, Tetsuhisa
Ueno, Shinji
Kuniyoshi, Kazuki
Hayashi, Takaaki
Katagiri, Satoshi
Kondo, Mineo
Kameya, Shuhei
Yoshitake, Kazutoshi
Fujinami, Kaoru
Iwata, Takeshi
Miyake, Yozo
description To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings. Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed. The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed. The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.
doi_str_mv 10.1167/iovs.19-27486
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2314574287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2314574287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223</originalsourceid><addsrcrecordid>eNpNkDFPwzAUhC0EoqUwsiKPLCl-dmInIwQKSEUdKBND5DgvbVASBztB6r-nLQUx3Q3f3fARcglsCiDVTWW__BSSgKswlkdkDFHEg0jF4vhfH5Ez7z8Y4wCcnZKRAMUjkPGYvKd11VZG1_S11yv01JZ0YcxQ9_RFb0M7er_xvbPdekPvtMeC2pYuun6_Se0aHbYG6dI2duV0t64MnVVtUbUrf05OSl17vDjkhLzNHpbpUzBfPD6nt_PAiCTuAy55wUJI8pDFORqFXItIhzkYHsoSCxOWpsRY5kYYyRAAchScYcyUlMC5mJDrn9_O2c8BfZ81lTdY17pFO_iMCwgjFfJYbdHgBzXOeu-wzDpXNdptMmDZzme285lBku19bvmrw_WQN1j80b8CxTeqlXGh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314574287</pqid></control><display><type>article</type><title>Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings</title><source>PubMed Central</source><creator>Nakamura, Natsuko ; Tsunoda, Kazushige ; Mizuno, Yoshinobu ; Usui, Tomoaki ; Hatase, Tetsuhisa ; Ueno, Shinji ; Kuniyoshi, Kazuki ; Hayashi, Takaaki ; Katagiri, Satoshi ; Kondo, Mineo ; Kameya, Shuhei ; Yoshitake, Kazutoshi ; Fujinami, Kaoru ; Iwata, Takeshi ; Miyake, Yozo</creator><creatorcontrib>Nakamura, Natsuko ; Tsunoda, Kazushige ; Mizuno, Yoshinobu ; Usui, Tomoaki ; Hatase, Tetsuhisa ; Ueno, Shinji ; Kuniyoshi, Kazuki ; Hayashi, Takaaki ; Katagiri, Satoshi ; Kondo, Mineo ; Kameya, Shuhei ; Yoshitake, Kazutoshi ; Fujinami, Kaoru ; Iwata, Takeshi ; Miyake, Yozo</creatorcontrib><description>To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings. Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed. The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed. The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.</description><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.19-27486</identifier><identifier>PMID: 31725168</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Disease Progression ; Eye Proteins - genetics ; Female ; Fluorescein Angiography ; Humans ; Macular Degeneration - diagnosis ; Macular Degeneration - genetics ; Macular Degeneration - physiopathology ; Male ; Middle Aged ; Photoreceptor Cells, Vertebrate - physiology ; Retina - diagnostic imaging ; Retina - physiopathology ; Retinal Pigment Epithelium - physiology ; Tomography, Optical Coherence ; Visual Acuity - physiology</subject><ispartof>Investigative ophthalmology &amp; visual science, 2019-11, Vol.60 (14), p.4691-4700</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223</citedby><cites>FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31725168$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakamura, Natsuko</creatorcontrib><creatorcontrib>Tsunoda, Kazushige</creatorcontrib><creatorcontrib>Mizuno, Yoshinobu</creatorcontrib><creatorcontrib>Usui, Tomoaki</creatorcontrib><creatorcontrib>Hatase, Tetsuhisa</creatorcontrib><creatorcontrib>Ueno, Shinji</creatorcontrib><creatorcontrib>Kuniyoshi, Kazuki</creatorcontrib><creatorcontrib>Hayashi, Takaaki</creatorcontrib><creatorcontrib>Katagiri, Satoshi</creatorcontrib><creatorcontrib>Kondo, Mineo</creatorcontrib><creatorcontrib>Kameya, Shuhei</creatorcontrib><creatorcontrib>Yoshitake, Kazutoshi</creatorcontrib><creatorcontrib>Fujinami, Kaoru</creatorcontrib><creatorcontrib>Iwata, Takeshi</creatorcontrib><creatorcontrib>Miyake, Yozo</creatorcontrib><title>Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings</title><title>Investigative ophthalmology &amp; visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings. Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed. The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed. The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Child</subject><subject>Disease Progression</subject><subject>Eye Proteins - genetics</subject><subject>Female</subject><subject>Fluorescein Angiography</subject><subject>Humans</subject><subject>Macular Degeneration - diagnosis</subject><subject>Macular Degeneration - genetics</subject><subject>Macular Degeneration - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Photoreceptor Cells, Vertebrate - physiology</subject><subject>Retina - diagnostic imaging</subject><subject>Retina - physiopathology</subject><subject>Retinal Pigment Epithelium - physiology</subject><subject>Tomography, Optical Coherence</subject><subject>Visual Acuity - physiology</subject><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpNkDFPwzAUhC0EoqUwsiKPLCl-dmInIwQKSEUdKBND5DgvbVASBztB6r-nLQUx3Q3f3fARcglsCiDVTWW__BSSgKswlkdkDFHEg0jF4vhfH5Ez7z8Y4wCcnZKRAMUjkPGYvKd11VZG1_S11yv01JZ0YcxQ9_RFb0M7er_xvbPdekPvtMeC2pYuun6_Se0aHbYG6dI2duV0t64MnVVtUbUrf05OSl17vDjkhLzNHpbpUzBfPD6nt_PAiCTuAy55wUJI8pDFORqFXItIhzkYHsoSCxOWpsRY5kYYyRAAchScYcyUlMC5mJDrn9_O2c8BfZ81lTdY17pFO_iMCwgjFfJYbdHgBzXOeu-wzDpXNdptMmDZzme285lBku19bvmrw_WQN1j80b8CxTeqlXGh</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Nakamura, Natsuko</creator><creator>Tsunoda, Kazushige</creator><creator>Mizuno, Yoshinobu</creator><creator>Usui, Tomoaki</creator><creator>Hatase, Tetsuhisa</creator><creator>Ueno, Shinji</creator><creator>Kuniyoshi, Kazuki</creator><creator>Hayashi, Takaaki</creator><creator>Katagiri, Satoshi</creator><creator>Kondo, Mineo</creator><creator>Kameya, Shuhei</creator><creator>Yoshitake, Kazutoshi</creator><creator>Fujinami, Kaoru</creator><creator>Iwata, Takeshi</creator><creator>Miyake, Yozo</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20191101</creationdate><title>Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings</title><author>Nakamura, Natsuko ; Tsunoda, Kazushige ; Mizuno, Yoshinobu ; Usui, Tomoaki ; Hatase, Tetsuhisa ; Ueno, Shinji ; Kuniyoshi, Kazuki ; Hayashi, Takaaki ; Katagiri, Satoshi ; Kondo, Mineo ; Kameya, Shuhei ; Yoshitake, Kazutoshi ; Fujinami, Kaoru ; Iwata, Takeshi ; Miyake, Yozo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Child</topic><topic>Disease Progression</topic><topic>Eye Proteins - genetics</topic><topic>Female</topic><topic>Fluorescein Angiography</topic><topic>Humans</topic><topic>Macular Degeneration - diagnosis</topic><topic>Macular Degeneration - genetics</topic><topic>Macular Degeneration - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Photoreceptor Cells, Vertebrate - physiology</topic><topic>Retina - diagnostic imaging</topic><topic>Retina - physiopathology</topic><topic>Retinal Pigment Epithelium - physiology</topic><topic>Tomography, Optical Coherence</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakamura, Natsuko</creatorcontrib><creatorcontrib>Tsunoda, Kazushige</creatorcontrib><creatorcontrib>Mizuno, Yoshinobu</creatorcontrib><creatorcontrib>Usui, Tomoaki</creatorcontrib><creatorcontrib>Hatase, Tetsuhisa</creatorcontrib><creatorcontrib>Ueno, Shinji</creatorcontrib><creatorcontrib>Kuniyoshi, Kazuki</creatorcontrib><creatorcontrib>Hayashi, Takaaki</creatorcontrib><creatorcontrib>Katagiri, Satoshi</creatorcontrib><creatorcontrib>Kondo, Mineo</creatorcontrib><creatorcontrib>Kameya, Shuhei</creatorcontrib><creatorcontrib>Yoshitake, Kazutoshi</creatorcontrib><creatorcontrib>Fujinami, Kaoru</creatorcontrib><creatorcontrib>Iwata, Takeshi</creatorcontrib><creatorcontrib>Miyake, Yozo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Investigative ophthalmology &amp; visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakamura, Natsuko</au><au>Tsunoda, Kazushige</au><au>Mizuno, Yoshinobu</au><au>Usui, Tomoaki</au><au>Hatase, Tetsuhisa</au><au>Ueno, Shinji</au><au>Kuniyoshi, Kazuki</au><au>Hayashi, Takaaki</au><au>Katagiri, Satoshi</au><au>Kondo, Mineo</au><au>Kameya, Shuhei</au><au>Yoshitake, Kazutoshi</au><au>Fujinami, Kaoru</au><au>Iwata, Takeshi</au><au>Miyake, Yozo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings</atitle><jtitle>Investigative ophthalmology &amp; visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>60</volume><issue>14</issue><spage>4691</spage><epage>4700</epage><pages>4691-4700</pages><issn>1552-5783</issn><eissn>1552-5783</eissn><abstract>To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings. Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed. The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed. The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.</abstract><cop>United States</cop><pmid>31725168</pmid><doi>10.1167/iovs.19-27486</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-5783
ispartof Investigative ophthalmology & visual science, 2019-11, Vol.60 (14), p.4691-4700
issn 1552-5783
1552-5783
language eng
recordid cdi_proquest_miscellaneous_2314574287
source PubMed Central
subjects Adolescent
Adult
Aged
Aged, 80 and over
Child
Disease Progression
Eye Proteins - genetics
Female
Fluorescein Angiography
Humans
Macular Degeneration - diagnosis
Macular Degeneration - genetics
Macular Degeneration - physiopathology
Male
Middle Aged
Photoreceptor Cells, Vertebrate - physiology
Retina - diagnostic imaging
Retina - physiopathology
Retinal Pigment Epithelium - physiology
Tomography, Optical Coherence
Visual Acuity - physiology
title Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A23%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Stages%20of%20Occult%20Macular%20Dystrophy%20Based%20on%20Optical%20Coherence%20Tomographic%20Findings&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Nakamura,%20Natsuko&rft.date=2019-11-01&rft.volume=60&rft.issue=14&rft.spage=4691&rft.epage=4700&rft.pages=4691-4700&rft.issn=1552-5783&rft.eissn=1552-5783&rft_id=info:doi/10.1167/iovs.19-27486&rft_dat=%3Cproquest_cross%3E2314574287%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c398t-262d0419b408bec7e2a35a4b1c246fedc4fcfe86bc3c60e111be320e807661223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2314574287&rft_id=info:pmid/31725168&rfr_iscdi=true